SoftOx Solutions is trading 5.45% up at NOK 0.09, with no confirmed company-specific catalyst identified for August 25, 2026.

  • No new company-specific announcement dated August 25, 2026 was identified to explain the move.
  • The latest update reported that the first patient had been dosed in the SIS-03 proof-of-concept trial on August 11; timing does not establish a direct catalyst for this session.
  • Trading appears lightly supported, with no confirmed news-driven explanation.